Silico Research Limited Company Profile

23:35 EST 15th December 2018 | BioPortfolio

Silico Research is a research organisation dedicated to providing original research focusing on scientific research and complex inter-organisational relationships, transactions, attitudes and opinions. Silico’s expertise is in using innovative technologies to execute large, complex, borderless and multi-dimensional databases and research projects polling senior executives, professionals and opinion leaders.
Silico's particular expertise is in the area of alliances, mergers and acquisitions, research, intellectual property, professional services and clinical trials. Silico now has one of the largest databases available linking companies, patents, patent assignments, clinical trials, scientific papers and research activities for a deep insight into trends in the industry and individual companies and organisations in the sector through deep taxonomies and advanced classification techniques including Bayesian inference.


Cobalt House, Centre Court, Sir Thomas Longley Road
United Kingdom


Phone: 44 1634 731 614
Fax: 44 1634 731644

News Articles [60 Associated News Articles listed on BioPortfolio]

In silico farming drives next wave in agriculture - @ericsmalley  #precisionagriculture

In silico farming drives next wave in agriculture - @ericsmalley  #precisionagriculture #machinelearning

Fatty liver disease pandemic needs 'gold standard' human-relevant research

(Humane Society International) New study calls for human-based tools to unravel the pathogenesis of non-alcoholic steatohepatitis (NASH). The contribution of in silico, in vitro and pathways-based sys...

Generic Industry Wants US FDA To Advance Research To Eliminate Need For Clinical BE Studies

Association For Accessible Medicines representatives say animal studies and in-silico trials could reduce the need for BE studies, but OGD...   

bioinformatics, genomics, pharmacology, toxicology, microarrays, in silico


AstraZeneca Becomes the First Lhasa Member to Realise the Benefits of Mirabilis Through SaaS

LEEDS, England, October 4, 2018 /PRNewswire/ -- Lhasa Limited, an educational charity which creates state-of-the-art in silico prediction and database systems, today announced that AstraZeneca has...

Quotient Limited Announces Details of Investor Day

JERSEY, Channel Islands, July 16, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced details of its investor day held at the NASDAQ he...

Quotient Limited to Host Investor Day on July 16, 2018

JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July ...

Quotient Limited to Participate in the Jefferies 2018 London Healthcare Conference

JERSEY, Channel Islands, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Quotient (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chief Financial Officer, Chris Lindop,...

PubMed Articles [895 Associated PubMed Articles listed on BioPortfolio]

New in Silico Trends in Food Toxicology.

Ever growing numbers of chemicals in food and drinking water make it impossible to address safety by classical approaches in toxicology. In silico chemical methods could be a first-line for hazard cha...

Prevalence and in silico analysis of missense mutations in the PROS1 gene in the Swedish population: The SweGen dataset.

Neuroinformatics and Computational Modelling as Complementary Tools for Neurotoxicology Studies.

Neuroinformatics is an area of science that aims to integrate neuroscience data and develop modern computational tools to increase our understanding of the functions of the nervous system in health an...

Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort.

In Silico Prediction of Major Clearance Pathways of Drugs among 9 Routes with Two-Step Support Vector Machines.

The clearance pathways of drugs are critical elements for understanding the pharmacokinetics of drugs. We previously developed in silico systems to predict the five clearance pathway using a rectangul...

Clinical Trials [1142 Associated Clinical Trials listed on BioPortfolio]

Panomics Relationships in the Epidemiology of Cancer Through In Silico Expression (PRECISE)

PRECISE is a study to discover new detection, prognosis and treatment biomarkers for cancer. This is a prospective, multi-center, observational study designed to collect de-identified bios...

Mitochondrial Genetics of Presbycusis

The main goal of this study is to identify mitochondrial mutations associated with presbycusis. Patients affected by severe presbycusis and normal hearing controls (according to ISO7029 no...

A Study of the Safety of Targeted AAA Screening

This study is a data linkage project within which we aim to model the impact on the NHS AAA Screening programme of a targeted approach to screening by targeting men who smoke. This in-sili...

ROCOCO - Low Grade Glioma

The cost of particle therapy (PT) are considerably higher than conventional radiotherapy (RT) with photons. Considering potential dosimetric advantages of PT, it is necessary to determine ...

Feasibility Study to Evaluate the Hybrid-Logic Closed Loop System in Type 1 Diabetes The DREMED Trail

Closed loop technology has been shown to reduce both hypoglycemia and hyperglycemia, as well as reduce glycemic variability. Several groups around the world investigate efforts in develop...

Companies [1159 Associated Companies listed on BioPortfolio]

Silico Research Limited

Silico Research is a research organisation dedicated to providing original research focusing on scientific research and complex inter-organisational relationships, transactions, attitudes and opinions...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

In Silico Biosciences, Inc


Compugen Ltd. Compugen Ltd.

Compugen is a leading therapeutic product discovery company focused on therapeutic proteins and monoclonal antibodies to address important unmet needs in the fields of immunology ...

Compugen Ltd.

Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen's discovery efforts are b...

More Information about "Silico Research Limited" on BioPortfolio

We have published hundreds of Silico Research Limited news stories on BioPortfolio along with dozens of Silico Research Limited Clinical Trials and PubMed Articles about Silico Research Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Silico Research Limited Companies in our database. You can also find out about relevant Silico Research Limited Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record